Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
DPL
DPL

Dipna Pharmachem Ltd.

BSE: 543594
SME
Sector: Healthcare
Industry: Pharmaceuticals
3.89-0.1 (-1.52%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
10.23
P/E (TTM)
3.89
P/B
0.16
P/S (TTM)
0.08
EV/EBITDA
4.45
CAPE (5Y)
5.20
ROE (TTM)
5.22
ROCE (TTM)
7.59
ROA (TTM)
1.56
Avg 3Y ROE
3.76
Earnings 3Y CAGR
16.90
Sales 3Y CAGR
8.91
Sales 5Y CAGR
33.02
Debt/Equity
0.21
Consensus TP
-
Strong Buy %
-
Promoter Holding
9.13
Pledged %
0.00

Share Price

Track Dipna Pharmachem Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

3.89-0.1 (-1.52%)
-80.75% in past 1 year
1 Week returns: -2.02 %
Low
3.9
High
4.1
1 Month returns: -15.62 %
Low
3.9
High
4.9
1 Year returns: -80.75 %
Low
3.9
High
20.5
3 Year CAGR: -33.34 %
Low
3.9
High
26.3
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of Dipna Pharmachem Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median

PE TTM of 3.89 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -87.23%

What is P/E Ratio?

Median: 30.47
Value 3.89
-0.82614.73
Negative
Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.0212302.

Financial Snapshot

See detailed analysis

Multi-year trends for Dipna Pharmachem Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
00k0k0k0k99.9 CrMar 2023164.3 CrMar 2024124.9 CrMar 2025129.1 CrMar 2026
Profit After Tax FY
00k0k0k0.9 CrMar 20231.1 CrMar 20241.0 CrMar 20252.6 CrMar 2026
ROE FY
0%2%4%6%8%7.0%Mar 20233.5%Mar 20242.6%Mar 20255.2%Mar 2026
EBITDA FY
00k0k0k2.3 CrMar 20233.4 CrMar 20243.4 CrMar 20255.0 CrMar 2026

Dipna Pharmachem Ltd. Shareholding Pattern

Quarterly breakdown of Dipna Pharmachem Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Sep 2022Mar 2023Sep 2023Dec 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Jun 2026
Total Promoter
66.56
66.56
57.19
9.98
9.98
9.98
9.98
9.98
9.13
9.13
Indian Promoter
66.56
66.56
57.19
9.98
9.98
9.98
9.98
9.98
9.13
9.13
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Mutual Funds / UTI
-
-
-
-
-
-
-
-
-
-
FI/Bank/Insurance
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Govt
-
-
-
-
-
-
-
-
-
-
FII
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non-Institution
33.44
33.44
42.81
90.02
90.02
90.02
90.02
90.02
90.87
90.87
Bodies Corporate
0.18
0.10
0.05
2.64
2.64
2.09
4.58
5.63
0.86
0.89
Others (incl. Retail)
No. of shareholders
33.26
1,102
33.34
985
42.76
1,072
87.38
1,788
87.38
1,788
87.93
2,635
85.44
1,979
84.39
1,727
90.01
1,702
89.98
1,773

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Dipna Pharmachem Ltd. is not part of any tracked index.

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Dipna Pharmachem Ltd. shares as reported to NSE and BSE.

Company Profile

Overview of Dipna Pharmachem Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company is primarily engaged in a single segment, which is pharmaceutical trading. Its products ...
Incorporated on
19 Jul 2011
Last Annual
31 Mar 2026
Last Interim
-
No. of Employees
-
IPO date
08 Sep 2022
Free Float
1,24,63,300
Address
-

Frequently Asked Questions

What is the current share price of Dipna Pharmachem Ltd.?
The current share price of Dipna Pharmachem Ltd. is ₹ 3.89 as of 23 Oct 2026.
What is the market capitalisation of Dipna Pharmachem Ltd.?
The market capitalisation of Dipna Pharmachem Ltd. stands at ₹ 10.23 Cr.
What is the PE ratio of Dipna Pharmachem Ltd.?
The Price-to-Earnings (PE) ratio of Dipna Pharmachem Ltd. is 3.89 as of the latest trailing twelve months data.
What is the ROE and ROCE of Dipna Pharmachem Ltd.?
Dipna Pharmachem Ltd. has a Return on Equity (ROE) of 5.22% and a Return on Capital Employed (ROCE) of 7.59% as per the latest financial reports.
What is the 52-week high and low of Dipna Pharmachem Ltd.?
The 52-week high of Dipna Pharmachem Ltd. is - and the 52-week low is -.
What is the dividend yield of Dipna Pharmachem Ltd.?
The dividend yield of Dipna Pharmachem Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Dipna Pharmachem Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 89.98% of Dipna Pharmachem Ltd. shares.
What sector does Dipna Pharmachem Ltd. belong to?
Dipna Pharmachem Ltd. operates in the Healthcare sector.
What is the beta of Dipna Pharmachem Ltd.?
The beta of Dipna Pharmachem Ltd. is 0.34, indicating its price volatility relative to the broader market.
What is the RSI of Dipna Pharmachem Ltd.?
The 14-day Relative Strength Index (RSI) of Dipna Pharmachem Ltd. is 37.52, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.